Released today, The Global Cannabis Report: Second Edition provides an overview of the development of international cannabis markets, and considers how they might develop in the near future.
The Global Cannabis Report: Second Edition highlights how the global cannabis industry is heading into a progressive period marked by widespread legalisation, innovation and considerable growth.
As highlighted in the report, Prohibition Partners finds combined global sales of CBD, medical and adult-use cannabis topped US$37.4 billion in 2021, and could rise to US$102 billion by 2026.
Adult-use markets in the US and Canada remain the most important regions in the world for cannabis sales, but international markets including Germany, Israel and Australia will develop considerably over the next five years.
While the COVID-19 lockdown period saw record-breaking sales of cannabis in multiple regions, legislative developments have been interrupted, bringing delays in the development of cannabis market value across the globe.
The Global Cannabis Report: Second Edition provides an overview of the development of cannabis markets at the international level, and considers how they might develop in the near future. It also covers some of the most interesting and pertinent global trends in the industry.
The report is split into four key sections:
- An overview of the major trends in legalisation and market development across the globe,
- An overview of Prohibition Partners’ global market sizing estimates for the next five years,
- A review of key region-specific trends,
- Interviews with industry experts in key areas of the global market
Legalisation Trends
As of late 2021 only Uruguay, Canada and a handful of states in the US have fully legalised cannabis for adult-use, but these will be joined by several international markets soon. Mexico and Israel are primed for full legalisation of adult-use cannabis in 2022, while the Netherlands and Switzerland are preparing for their legal pilot trials.
